# QUANTRX BIOMEDICAL CORP

QUANTRX BIOMEDICAL CORP is a company headquartered in Tualatin, OR, United States.

## Company overview

- **Legal name:** QUANTRX BIOMEDICAL CORP
- **Former names in filing history:** AFEM MEDICAL CORP (1997-11-12 to 2006-02-17); ATHENA MEDICAL CORP (1995-08-14 to 1997-05-20)
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** Tualatin, OR, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0000820608

## About

QUANTRX BIOMEDICAL CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000820608, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2022-04-15, it reported net income of USD -260,042; total assets of USD 5,950 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Net income:** -$260,042 (USD -260,042)
- **Total assets:** $5,950 (USD 5,950)
- **Cash and equivalents:** $5,950 (USD 5,950)
- **Operating cash flow:** -$49,478 (USD -49,478)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$252,734 (USD -252,734)
- **Total assets:** $55,428 (USD 55,428)
- **Cash and equivalents:** $55,428 (USD 55,428)
- **Operating cash flow:** -$74,923 (USD -74,923)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$621,920 (USD -621,920)
- **Total assets:** $137,351 (USD 137,351)
- **Cash and equivalents:** $130,351 (USD 130,351)
- **Operating cash flow:** -$191,673 (USD -191,673)

### FY2018 (period ended 2018-12-31)

- **Net income:** -$736,850 (USD -736,850)
- **Total assets:** $581,788 (USD 581,788)
- **Cash and equivalents:** $322,024 (USD 322,024)
- **Operating cash flow:** -$257,920 (USD -257,920)

## Recent SEC filings

- Form 10-Q — filed 2022-11-14 — period 2022-09-30
- Form 8-K — filed 2022-08-24 — period 2022-08-22
- Form 10-Q — filed 2022-08-22 — period 2022-06-30
- Form 10-Q — filed 2022-05-16 — period 2022-03-31
- Form 10-K — filed 2022-04-15 — period 2021-12-31
- Form 10-Q — filed 2021-11-16 — period 2021-09-30 — FORM 10-Q
- Form 10-Q — filed 2021-08-16 — period 2021-06-30 — QUARTERLY REPORT
- Form 10-Q — filed 2021-05-17 — period 2021-03-31 — QUARTERLY REPORT
- Form 10-K — filed 2021-04-15 — period 2020-12-31 — ANNUAL REPORT
- Form 10-Q — filed 2020-11-17 — period 2020-09-30 — QUARTERLY REPORT
- Form 10-Q — filed 2020-08-14 — period 2020-06-30 — QUARTERLY REPORT
- Form 10-Q — filed 2020-05-20 — period 2020-03-31 — QUARTERLY REPORT

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/quantrx-biomedical-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology